American Well (AMWL) Set to Announce Quarterly Earnings on Tuesday

American Well (NYSE:AMWL) is expected to issue its Q3 2026 results after the market closes on Tuesday, November 3rd. Analysts expect American Well to announce earnings of ($0.66) per share and revenue of $47.29 million for the quarter. Interested persons may review the information on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Tuesday, November 3, 2026 at 5:00 PM ET.

American Well (NYSE:AMWL) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.59) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.86) by $0.27. The company had revenue of $52.05 million during the quarter, compared to the consensus estimate of $49.87 million. American Well had a negative net margin of 35.75% and a negative return on equity of 30.12%. On average, analysts expect American Well to post ($2.56) EPS for the current fiscal year and ($1.58) EPS for the next fiscal year.

American Well Trading Down 0.3%

Shares of American Well stock opened at $13.53 on Tuesday. The firm has a market capitalization of $223.86 million, a PE ratio of -2.84 and a beta of 1.67. American Well has a 12 month low of $3.71 and a 12 month high of $14.56. The business’s 50-day moving average price is $12.78 and its 200-day moving average price is $8.74.

Insider Buying and Selling

In related news, insider Phyllis Gotlib sold 6,677 shares of the firm’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $13.00, for a total value of $86,801.00. Following the completion of the sale, the insider owned 142,504 shares of the company’s stock, valued at $1,852,552. This trade represents a 4.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Dmitry Zamansky sold 8,442 shares of the firm’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $13.00, for a total value of $109,746.00. Following the completion of the sale, the insider directly owned 224,178 shares of the company’s stock, valued at $2,914,314. The trade was a 3.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 19,457 shares of company stock valued at $248,519. 12.84% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on AMWL shares. Truist Financial set a $12.00 price target on American Well and gave the stock a “hold” rating in a research note on Thursday, August 13th. Wells Fargo & Company upped their price objective on shares of American Well from $9.00 to $16.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Weiss Ratings reiterated a “sell (d-)” rating on shares of American Well in a report on Thursday, October 15th. Finally, Needham & Company LLC reissued a “hold” rating on shares of American Well in a research note on Wednesday, August 5th. One analyst has rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, American Well presently has an average rating of “Hold” and a consensus price target of $9.50.

About American Well

American Well, doing business as Amwell, is a digital healthcare company that provides technology and services for virtual care. Its platform connects patients with healthcare professionals through video and other digital channels, supporting services such as urgent care, behavioral health, primary care and specialty consultations.

Amwell primarily serves health systems, health plans, employers and other healthcare organizations. Its offerings include the Amwell Converge platform, which is designed to help organizations develop, manage and integrate digital care programs with existing clinical workflows and healthcare systems.

Founded in 2006 by brothers Ido and Roy Schoenberg, the company was formerly known as American Well and adopted the Amwell brand in 2020.